Dirk Roymans

2.2k total citations
35 papers, 1.5k citations indexed

About

Dirk Roymans is a scholar working on Epidemiology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Dirk Roymans has authored 35 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 13 papers in Molecular Biology and 10 papers in Infectious Diseases. Recurrent topics in Dirk Roymans's work include Respiratory viral infections research (17 papers), Viral gastroenteritis research and epidemiology (10 papers) and Virology and Viral Diseases (5 papers). Dirk Roymans is often cited by papers focused on Respiratory viral infections research (17 papers), Viral gastroenteritis research and epidemiology (10 papers) and Virology and Viral Diseases (5 papers). Dirk Roymans collaborates with scholars based in Belgium, United States and France. Dirk Roymans's co-authors include Herman Slegers, Bert Grobben, Roel Willems, Anil Koul, Jason S. McLellan, Geert Mannens, W. Meuldermans, Katelijne Anciaux, Eddy L. Esmans and Pieter Annaert and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and PLoS ONE.

In The Last Decade

Dirk Roymans

35 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dirk Roymans Belgium 23 556 541 299 217 159 35 1.5k
Michèle Maurice France 24 230 0.4× 544 1.0× 102 0.3× 124 0.6× 97 0.6× 35 1.6k
Morten Luhr Norway 9 1.0k 1.8× 936 1.7× 136 0.5× 190 0.9× 82 0.5× 12 1.9k
Franco Turrini Italy 27 300 0.5× 883 1.6× 118 0.4× 82 0.4× 361 2.3× 50 2.6k
Ansgar Brüning Germany 24 290 0.5× 793 1.5× 102 0.3× 61 0.3× 85 0.5× 57 1.6k
Youcef Mehellou United Kingdom 20 283 0.5× 1.1k 2.0× 567 1.9× 54 0.2× 85 0.5× 40 1.9k
Yong Fu China 14 540 1.0× 893 1.7× 206 0.7× 38 0.2× 196 1.2× 23 1.8k
Katarzyna Rückemann-Dziurdzińska Poland 13 192 0.3× 424 0.8× 125 0.4× 67 0.3× 50 0.3× 31 1.2k
Andreas Jekle United States 19 225 0.4× 1.2k 2.2× 229 0.8× 78 0.4× 68 0.4× 43 1.8k
Shouyue Zhang China 20 245 0.4× 736 1.4× 52 0.2× 64 0.3× 135 0.8× 34 1.2k
Takayuki Nakashima Japan 18 671 1.2× 816 1.5× 166 0.6× 35 0.2× 78 0.5× 36 1.7k

Countries citing papers authored by Dirk Roymans

Since Specialization
Citations

This map shows the geographic impact of Dirk Roymans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Roymans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Roymans more than expected).

Fields of papers citing papers by Dirk Roymans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Roymans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Roymans. The network helps show where Dirk Roymans may publish in the future.

Co-authorship network of co-authors of Dirk Roymans

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Roymans. A scholar is included among the top collaborators of Dirk Roymans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Roymans. Dirk Roymans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Verstraelen, Sandra, Dirk Roymans, An Jacobs, et al.. (2024). Proof of stability of an RSV Controlled Human Infection Model challenge agent. Virology Journal. 21(1). 112–112. 2 indexed citations
2.
Carbajo, Rodrigo J., Edgar Jacoby, Yanting Yin, et al.. (2024). Structure–Activity Relationship of Oxacyclo- and Triazolo-Containing Respiratory Syncytial Virus Polymerase Inhibitors. ACS Medicinal Chemistry Letters. 15(9). 1549–1558. 2 indexed citations
3.
Sutto‐Ortiz, Priscila, Sergey Tcherniuk, Pravien Abeywickrema, et al.. (2021). The methyltransferase domain of the Respiratory Syncytial Virus L protein catalyzes cap N7 and 2’-O-methylation. PLoS Pathogens. 17(5). e1009562–e1009562. 20 indexed citations
4.
5.
Amssoms, Katie, Freek Cox, Ellen Van Gulck, et al.. (2019). Development of a Stable Respiratory Syncytial Virus Pre-Fusion Protein Powder Suitable for a Core-Shell Implant with a Delayed Release in Mice: A Proof of Concept Study. Pharmaceutics. 11(10). 510–510. 1 indexed citations
6.
Ritschel, Tina, Gabriel Pascual, Just P. J. Brakenhoff, et al.. (2018). Structural basis for recognition of the central conserved region of RSV G by neutralizing human antibodies. PLoS Pathogens. 14(3). e1006935–e1006935. 54 indexed citations
7.
Ispas, Gabriela, Anil Koul, Johan Verbeeck, et al.. (2015). Antiviral Activity of TMC353121, a Respiratory Syncytial Virus (RSV) Fusion Inhibitor, in a Non-Human Primate Model. PLoS ONE. 10(5). e0126959–e0126959. 35 indexed citations
8.
Battles, Michael B., Johannes P. M. Langedijk, Supranee Chaiwatpongsakorn, et al.. (2015). Molecular mechanism of respiratory syncytial virus fusion inhibitors. Nature Chemical Biology. 12(2). 87–93. 120 indexed citations
9.
Roymans, Dirk, et al.. (2013). Evaluation of Antiviral Efficacy Against Human Respiratory Syncytial Virus Using Cotton Rat and Mouse Models. Methods in molecular biology. 1030. 365–372. 3 indexed citations
10.
Olszewska, Wieslawa, Gabriela Ispas, Corinna Schnoeller, et al.. (2010). Antiviral and lung protective activity of a novel respiratory syncytial virus fusion inhibitor in a mouse model. European Respiratory Journal. 38(2). 401–408. 42 indexed citations
11.
Roymans, Dirk, Pieter Annaert, Jos Van Houdt, et al.. (2005). EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTES. Drug Metabolism and Disposition. 33(7). 1004–1016. 56 indexed citations
12.
Vermeir, Marc, Pieter Annaert, Rao N. V. S. Mamidi, et al.. (2005). Cell-based models to study hepatic drug metabolism and enzyme induction in humans. Expert Opinion on Drug Metabolism & Toxicology. 1(1). 75–90. 56 indexed citations
13.
Kolen, Kristof Van, Dirk Roymans, Daniel Bléro, et al.. (2004). Reactive blue 2 inhibition of cyclic AMP-dependent differentiation of rat C6 glioma cells by purinergic receptor-independent inactivation of phosphatidylinositol 3-kinase. Biochemical Pharmacology. 67(8). 1489–1498. 22 indexed citations
14.
Roymans, Dirk, Angelique M. Leone, J. Brandon Parker, et al.. (2003). Determination of cytochrome P450 1A2 and cytochrome P450 3A4 induction in cryopreserved human hepatocytes. Biochemical Pharmacology. 67(3). 427–437. 57 indexed citations
15.
Roymans, Dirk, Kris Vissenberg, Chris De Jonghe, et al.. (2001). Identification of the Tumor Metastasis Suppressor Nm23-H1/Nm23-R1 as a Constituent of the Centrosome. Experimental Cell Research. 262(2). 145–153. 34 indexed citations
16.
Roymans, Dirk, Kris Vissenberg, C. De Jonghe, et al.. (2001). Phosphatidylinositol 3‐kinase activity is required for the expression of glial fibrillary acidic protein upon cAMP‐dependent induction of differentiation in rat C6 glioma. Journal of Neurochemistry. 76(2). 610–618. 34 indexed citations
17.
Roymans, Dirk & Herman Slegers. (2001). Phosphatidylinositol 3‐kinases in tumor progression. European Journal of Biochemistry. 268(3). 487–498. 165 indexed citations
18.
19.
Grobben, Bert, et al.. (2000). Ecto‐nucleotide pyrophosphatase modulates the purinoceptor‐mediated signal transduction and is inhibited by purinoceptor antagonists. British Journal of Pharmacology. 130(1). 139–145. 52 indexed citations
20.
Anciaux, Katelijne, et al.. (1997). Inhibition of nucleoside diphosphate kinase (NDPK/nm23) by cAMP analogues. FEBS Letters. 400(1). 75–79. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michèle Maurice Breakdown of academic impact, for papers by Morten Luhr Breakdown of academic impact, for papers by Franco Turrini Breakdown of academic impact, for papers by Ansgar Brüning Breakdown of academic impact, for papers by Youcef Mehellou Breakdown of academic impact, for papers by Yong Fu Breakdown of academic impact, for papers by Katarzyna Rückemann-Dziurdzińska Breakdown of academic impact, for papers by Andreas Jekle Breakdown of academic impact, for papers by Shouyue Zhang Breakdown of academic impact, for papers by Takayuki Nakashima
Rankless by CCL
2026